Multidisciplinary ltidisciplinary Managem nagement ent of of - - PDF document

Sponsored by: the Association of Northern California Oncologists, Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and UCSF Helen Diller Family Comprehensive Cancer Center

Multidisciplinary ltidisciplinary Managem nagement ent of

• f

Cancers: Cancers: A Case Case‐based based

March 17‐19, 2017 Silverado Resort Napa, CA Course Course Co Co‐Di Direct rectors

• rs
• A. Dimitrios Colevas, MD

David Gandara, MD Margaret Tempero, MD

Acknowledgem Acknowledgement ent of

• f Comme

mmerc rcial Support Support

This CME activity was supported in part by educational grants from the following: Celgene Corporation Incyte Corporation Jazz Pharmaceuticals Novartis Pharmaceuticals Corporation Tesaro

Exhibitors Exhibitors

Alexion AMGEN Ariad Pharmaceuticals Astellas Oncology AstraZeneca Bayer Boehringer Ingelheim Pharmaceuticals Bristol‐Myers Squibb Oncology Eisai Exelixis Foundation Medicine Genentech BioOncology Genomic Health Genoptix GenPath Oncology Gilead Sciences Guardant Health Incyte Ipsen Biopharmaceuticals Janssen Biotech/ Johnson & Johnson Health Specialty Solutions Jazz Pharmaceuticals Lilly Oncology Merck Pfizer Hematology Pfizer Oncology Pharmacyclics Sandoz Biopharmaceuticals Sanofi Genzyme Sanofi Genzyme Endocrinology Sanofi Genzyme US Rare Diseases Seattle Genetics Stanford Referral Liaison Takeda Oncology (Millenium) Tesaro UC Davis Referral Liaison UCSF Referral Liaison

17th 17th Multid ltidisc isciplin linary Managem nagement nt of

• f Cancers:

Cancers: A CASE CASE‐BASED BASED APPROACH APPROACH

Educat Educational ional Object Objectives ives Upon completion of this program, attendees will be able to:  Develop multidisciplinary treatment strategies based on national clinical practice guidelines in oncology in order to improve quality of care for cancer patients;  Counsel patients on end‐of‐life care;  Discuss relevant clinical trials with cancer patients and refer appropriately. Accreditatio Accreditation The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. UCSF designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim

• nly the credit commensurate with the extent of their participation in the activity.

This CME activity meets the requirements under California Assembly Bill 1195, Continuing Education and Cultural and Linguistic Competency. NU NURSES: RSES: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. PHY PHYSIC ICIA IAN ASSISTA SSISTANTS: TS: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. PHA PHARMACY: CY: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit™.

Gen General In Inform formation ion

At Attendance tendance Veri Verifi ficati cation/Si

• n/Sign‐In

In Sheet Sheet / CME CME Certif rtific icates

Please remember to sign‐in on the sign‐in sheet when you check in at the MMC2017 Registration Desk on your first day. You only need to sign‐in once for the course, when you first check in. After the meeting, you will receive an email from Qualtrics@ucsf.edu with a link to complete your online Course Evaluation/ Electronic CME Certificate. Please make sure that you add this email to your safe senders list. The Qualtrics system will send you reminders to complete your CME Certificate Claiming until you complete it. Upon completing the Electronic CME Certificate, your CME certificate will be automatically generated to print and/or email yourself a copy. For smartphone users, you may want to take a photo of your certificate as some settings prevent you from emailing the certificate. The link will be available for 30 days after the last day of the course. However, after that date the link will expire and you will no longer be able to claim your credits online. You must then contact the Office of CME at registration@ocme.ucsf.edu to receive your certificate and a $15 administrative fee may be applied. Speake Speaker Su Survey rvey Your opinion is important to us – we do listen! The speaker survey is electronic and can be located on the following website: http://meded.ucsf.edu/cme/evaluation . Please complete this during the meeting or shortly after the conclusion of the meeting.

Securi Security ty

We urge caution with regard to your personal belongings and syllabus books. We are unable to replace these in the event of loss. Please do not leave any personal belongings unattended in the meeting room during lunch or breaks or overnight. Exhibit Exhibits Industry exhibits will be available outside the ballroom during breakfasts and breaks, and lunches. Final Final Presentat Presentations

• ns

A link to PDF versions of the final presentations will be sent via e‐mail approximately 3 – 4 weeks post course. Only presentations that have been authorized for inclusion by the presenter will be included

Federal Federal and and State State Law Law

Regarding Regarding Li Lingui nguisti stic Acce ccess ss an and Servi Services es for for Li Limited ted English lish Proficie icient Pers Persons

• ns

I. Purpose. This document is intended to satisfy the requirements set forth in California Business and Professions code 2190.1. California law requires physicians to obtain training in cultural and linguistic competency as part of their continuing medical education programs. This document and the attachments are intended to provide physicians with an overview of federal and state laws regarding linguistic access and services for limited English proficient (“LEP”) persons. Other federal and state laws not reviewed below also may govern the manner in which physicians and healthcare providers render services for disabled, hearing impaired or other protected categories II. Federal Law – Federal Civil Rights Act of 1964, Executive Order 13166, August 11, 2000, and Department of Health and Human Services (“HHS”) Regulations and LEP Guidance. The Federal Civil Rights Act of 1964, as amended, and HHS regulations require recipients of federal financial assistance (“Recipients”) to take reasonable steps to ensure that LEP persons have meaningful access to federally funded programs and services. Failure to provide LEP individuals with access to federally funded programs and services may constitute national origin discrimination, which may be remedied by federal agency enforcement action. Recipients may include physicians, hospitals, universities and academic medical centers who receive grants, training, equipment, surplus property and other assistance from the federal government. HHS recently issued revised guidance documents for Recipients to ensure that they understand their obligations to provide language assistance services to LEP persons. A copy of HHS’s summary document entitled “Guidance for Federal Financial Assistance Recipients Regarding Title VI and the Prohibition Against National Origin Discrimination Affecting Limited English Proficient Persons – Summary” is available at HHS’s website at: http://www.hhs.gov/ocr/lep/ . As noted above, Recipients generally must provide meaningful access to their programs and services for LEP persons. The rule, however, is a flexible one and HHS recognizes that “reasonable steps” may differ depending on the Recipient’s size and scope of services. HHS advised that Recipients, in designing an LEP program, should conduct an individualized assessment balancing four factors, including: (i) the number or proportion of LEP persons eligible to be served or likely to be encountered by the Recipient; (ii) the frequency with which LEP individuals come into contact with the Recipient’s program; (iii) the nature and importance of the program, activity or service provided by the Recipient to its beneficiaries; and (iv) the resources available to the Recipient and the costs of interpreting and translation services. Based on the Recipient’s analysis, the Recipient should then design an LEP plan based on five recommended steps, including: (i) identifying LEP individuals who may need assistance; (ii) identifying language assistance measures; (iii) training staff; (iv) providing notice to LEP persons; and (v) monitoring and updating the LEP plan. A Recipient’s LEP plan likely will include translating vital documents and providing either on‐site interpreters or telephone interpreter services, or using shared interpreting services with other Recipients. Recipients may take other reasonable steps depending on the emergent or non‐emergent needs of the LEP individual, such as hiring bilingual staff who are competent in the skills required for medical translation, hiring staff interpreters, or contracting with outside public or private agencies that provide interpreter services. HHS’s guidance provides detailed examples of the mix of services that a Recipient should consider and implement. HHS’s guidance also establishes a “safe harbor” that Recipients may elect to follow when determining whether vital documents must be translated into other languages. Compliance with the safe harbor will be strong evidence that the Recipient has satisfied its written translation obligations. In addition to reviewing HHS guidance documents, Recipients may contact HHS’s Office for Civil Rights for technical assistance in establishing a reasonable LEP plan. III. California Law – Dymally‐Alatorre Bilingual Services Act. The California legislature enacted the California’s Dymally‐Alatorre Bilingual Services Act (Govt. Code 7290 et seq.) in

• rder to ensure that California residents would appropriately receive services from public agencies regardless of the

person’s English language skills. California Government Code section 7291 recites this legislative intent as follows:

“The Legislature hereby finds and declares that the effective maintenance and development of a free and democratic society depends

• n the right and ability of its citizens and residents to communicate

with their government and the right and ability of the government to communicate with them. The Legislature further finds and declares that substantial numbers of persons who live, work and pay taxes in this state are unable, either because they do not speak or write English at all, or because their primary language is other than English, effectively to communicate with their government. The Legislature further finds and declares that state and local agency employees frequently are unable to communicate with persons requiring their services because of this language barrier. As a consequence, substantial numbers of persons presently are being denied rights and benefits to which they would

• therwise be entitled.

It is the intention of the Legislature in enacting this chapter to provide for effective communication between all levels of government in this state and the people of this state who are precluded from utilizing public services because of language barriers.” The Act generally requires state and local public agencies to provide interpreter and written document translation services in a manner that will ensure that LEP individuals have access to important government services. Agencies may employ bilingual staff, and translate documents into additional languages representing the clientele served by the agency. Public agencies also must conduct a needs assessment survey every two years documenting the items listed in Government Code section 7299.4, and develop an implementation plan every year that documents compliance with the

• Act. You may access a copy of this law at the following url: http://www.spb.ca.gov/bilingual/dymallyact.htm

Faculty Faculty List List

Conf Conference erence Course Course Di Director

• rs

A.

• A. Dimitrios

Dimitrios Colevas, Colevas, MD MD Stanford University David David Ga Gandar ndara, MD MD UC Davis Ma Margaret et Te Tempero, mpero, MD MD UC San Francisco

Panel Panel Chairs Chairs

Robe Robert rt Canter Canter, MD MD University of California, Davis Helen Helen K.

• K. Chew,

Chew, MD MD University of California, Davis Oliver Oliver Do Dorigo go, MD MD, Ph PhD Stanford University Pamela Pamela Mu Muns nster, MD MD University of California, San Francisco Joe Joel Ne Neal, al, MD MD Stanford University Kavit Kavitha Ram Ramchandran, handran, MD MD Stanford University Charles Charles Ryan Ryan, MD MD University of California, San Francisco Jose Joseph Tuscano, Tuscano, MD MD University of California, Davis Alan Alan Venook, Venook, MD MD University of California, San Francisco Sue Sue Yom, Yom, MD MD, Ph PhD University of California, San Francisco

Panelists lists

Rahul Rahul Agg Aggarw rwal, al, MD MD, UC San Francisco Alain Alain Alg Algazi, zi, MD MD, UC San Francisco Arch Archan ana Anant Ananthar aram aman, an, MD MD, UC San Francisco Charalam Charalambos (B (Babis) is) And Andreadis, eadis, MD MD, UC San Francisco Bet Beth M.

• M. Beadle,

Beadle, MD MD, Ph PhD, D, Stanford University Deept Deepti Behl, Behl, MD MD, Sutter Sacramento Em Emily ily Bergsland, Bergsland, MD MD, UC San Francisco Colin Colin Blakely Blakely, MD MD, PhD PhD, UC San Francisco Richard Richard J.

• J. Bol

Bold, MD MD, UC Davis Lisa Lisa Brown, Brown, MD MD, UC Davis Ma Mark rk Buyyounouski, Buyyounouski, MD MD, MS MS, Stanford Christ Christopher

• pher Chapm

Chapman, n, MD MD, UC San Francisco Le Lee May May Chen, Chen, MD MD, UC San Francisco Car Carlos

• s Cor

Corver era, a, MD MD, UC San Francisco Me Megan Daly, aly, MD MD, UC Davis Llo Lloyd Da Damon, mon, MD MD, UC San Francisco Mallika allika Dh Dhaw awan, an, MD MD, UC San Francisco Cher Cheryl yl Ew Ewing, g, MD MD, UC San Francisco Ma Mary ry Feng, Feng, MD MD, UC San Francisco Ge George

• rge A.
• A. Fi

Fisher, sher, MD MD, Ph PhD, D, Stanford Ma Matthew A.

• A. Gubens,

Gubens, MD MD, MS MS, UC San Francisco Patrick Patrick Ha Ha, MD MD, UC San Francisco Andrea Andrea Ha Harzsark, rzsark, MD MD, The Permanente Medical Group Joh John Hausdorff, rff, MD MD, Pacific Cancer Care Chr Chris Holsinger, lsinger, MD MD, Stanford Richard Richard Hop Hoppe, e, MD MD, Stanford Kat Kate Ho Horst, MD MD, Stanford Thierry Thierry Jahan, Jahan, MD MD, UC San Francisco Brian Brian A.

• A. Jon

Jonas, s, MD MD, PhD, PhD, UC Davis La Lawrence ce Kaplan, Kaplan, MD MD, UC San Francisco Ame Amer Ka Karam, ram, MD MD, Stanford Je Jed Ka Katzel, MD MD, The Permanente Medical Group Greg Greg Kau Kaufman, n, MD MD, Stanford Karen Karen Kelly, Kelly, MD MD, UC Davis Edward Edward Kim, Kim, MD MD, PhD, PhD, UC Davis Zach Zach Koon

• ntz,

tz, MD MD, Pacific Cancer Care Rajee Rajeev Krishnan, Krishnan, MD MD, UC Davis Shivaani Shivaani Ku Kummar, ar, MD MD, Stanford Pamela Pamela Kunz, Kunz, MD MD, Stanford Gary Gary Leisero Leiserowitz, itz, MD MD, MS MS, UC Davis Ron Ronald ald Le Levy, vy, MD MD, Stanford Tianhong Tianhong (Ti (Tina) a) Li, Li, MD MD, PhD PhD, UC Davis Yan Yan Li, Li, MD MD, The Permanente Medical Group Michaela chaela Liedt edtke, e, MD MD, Stanford Billy Billy W.

• W. Loo,

Loo, Jr.

• Jr. MD

MD, Stanford Lau Lauren Ma Maed eda, MD MD, Stanford David David Ma Magnus, Ph PhD, D, Stanford Mi Michael Mancuso, ncuso, MD MD, Stanford Jy Jyoti

• ti May

Mayade dev, MD MD, UC Davis Jennif nnifer Le Leah McNally ally MD MD, Stanford Bruno Bruno Me Medeiros, MD MD, Stanford Lyn Lynn Million, illion, MD MD, Stanford Daniel Daniel Mi Mirda, a, MD MD, Annadel Medical Group Leslie Leslie Oest Oesterich, erich, MD MD, UC Davis Ross Ross Okim imoto,

• to, MD

MD, UC San Francisco Chong Chong‐Xian Xian Pan, Pan, MD MD, PhD PhD, UC Davis Mi Minggui Pan Pan, MD MD, The Permanente Medical Group Bet Bethan an Powel Powell, MD MD, The Permanente Medical Group Mi Mike Rab Rabow, w, MD MD, UC San Francisco Shyam Shyam Ra Rao, MD MD, Ph PhD, D, UC Davis Jon Jonath than an Rie Riess, ss, MD MD, MS MS, UC Davis Ma Mack ck Ro Roac ach III, III, MD MD, UC San Francisco Aaron Aaron Ro Rosenber nberg, g, MD MD, UC Davis Hope Hope S.

• S. Rug

Rugo, MD MD, UC San Francisco Neil Neil Sh Shah, ah, MD MD, Ph PhD, D, UC San Francisco Jose Joseph B.

• B. Sh

Shrager, rager, MD MD, Stanford Ei Eila la Skinner, Skinner, MD MD, Stanford Ge George

• rge W.
• W. Sledge,

Sledge, Jr., Jr., MD MD, Stanford Sandy Sandy Srinivas, Srinivas, MD MD, Stanford Piyush Piyush Srivas ivastava, tava, MD MD, The Permanente Medical Group Betty tty Suh Suh‐Burgm Burgmann, nn, MD MD, The Permanente Medical Group Melinda linda Telli, Telli, MD MD, Stanford Diane Diane Tseng, Tseng, MD MD, Stanford Stefanie Stefanie Ueda, Ueda, MD MD, UC San Francisco Carling Carling Ur Ursem, sem, MD MD, UC San Francisco Brendan Brendan C.

• C. Visser,

sser, MD MD, Stanford Ann Ann Vo Von Gehr Gehr, MD MD, The Permanente Medical Group Rosann Rosanna Wust Wustrack, MD MD, UC San Francisco

Disclosures Disclosures

The following faculty speakers, moderators, and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity: Rahul Raj Aggarwal Alain Patrick Algazi Archana Anantharaman Charalambos Andreadis Beth M Beadle Deepti Behl Collin Blakely Richard J Bold Lisa M Brown Mark K Buyyounouski Robert J Canter Christopher H Chapman Lee‐may Chen Helen K Chew Alexander Dimitrios Colevas Carlos U Corvera Megan E Daly Lloyd E. Damon Mallika S. Dhawan Oliver Dorigo Cheryl A Ewing George Fisher Ann B Von Gehr Andrea Harzstark John Hausdorff Chris Holsinger Richard T Hoppe Kathleen Horst Thierry M Jahan Brian A Jonas Lawrence D. Kaplan Amer Karam Jed A Katzel Greg Kaufman Ed Kim Michael Z Koontz Rajeev Krishnan Shivaani Kummar Gary Scott Leiserowitz Tianhong Li Yan Li Lauren Maeda David C Magnus Michael Mancuso Jyoti Mayadev Leah McNally Lynn Million Daniel Paul Mirda Pamela N Munster Leslie Graustark Oesterich Ross A Okimoto Chong‐xian Pan Minggui Pan Bethan Powell Michael W. Rabow Shyam Rao Aaron S Rosenberg Charles J Ryan Neil P Shah Joseph Shrager Eila C. Skinner George W Sledge Piyush Srivastava Betty J Suh‐Burgmann Margaret A Tempero Stefanie M Ueda Carling J Ursem Brendan Christopher Visser Rosanna Wustrack The following faculty speakers have disclosed a financial interest/arrangement or affiliation with a commercial company who has provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity. All conflicts of interest have been resolved in accordance with the ACCME Standards for Commercial Support: Emily Bergsland lexicon ipsen AAA Consultant Consultant Consultant Mary Feng Genome Dx Biosciences Medivation/Astellas Celgene PFS Genomics Advisor or Reviewer Advisor or Reviewer Advisor or Reviewer Holder of Intellectual Property Rights

David R Gandara AstraZeneca/Medi Bristol‐Myers Squibb Clovis Oncology Genentech Johnson & Johnson Lilly Merck Novartis ARIAD Boehringer‐Ingelheim Celgene Guardant Health Mirati Pfizer Grant/Research Support/Consultant Grant/Research Support Grant/Research Support/Consultant Grant/Research Support/Consultant Grant/Research Support Grant/Research Support/Consultant Grant/Research Support/Consultant Grant/Research Support/Consultant Consultant Consultant Consultant Consultant Consultant Consultant Matthew Gubens Pfizer BMS Nektar ARIAD Genentech/Roche AstraZeneca Abbvie Celgene Merck Novartis OncoMed Consultant Consultant Consultant Consultant Grant/Research Support Consultant Consultant Consultant Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Patrick K Ha Bristol Myers Squibb Consultant Karen Lee Kelly Ariad AstraZeneca BMS Boehringer Ingelheim Genentech G1 Therapeutics Lilly Abbvie Celgene EMD Serono Five Prime Gilead Millennium NovartisTransgene Advisor or Reviewer Advisor or Reviewer Advisor or Reviewer Advisor or Reviewer Grant/Research Support/Advisor or Reviewer Advisor or Reviewer Grant/Research Support/Advisor or Reviewer Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support

Pamela Kunz Dicerna Esanex Oxigene Advanced Accelerator Application Genentech Ipsen Lexicon Phamaceuticals Merck Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support/Consultant/Honorarium Rec Grant/Research Support/Consultant/Honorarium Rec Grant/Research Support Ronald Levy Five Prime Therapeutics Beigene Corvus Quadriga Kite Pharma Pfizer Bristol Myers Squib Pharmacyclics Jansen Consultant Consultant Consultant Consultant Consultant Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Michaela Liedtke Takeda Prothena Pfizer Gilead Celgene Bluebird bio Grant/Research Support/Advisor or Reviewer Grant/Research Support/Advisor or Reviewer Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Billy W Loo, Jr Varian Medical Systems RaySearch Laboratories TibaRay Inc. Grant/Research Support/Honorarium Recipient Grant/Research Support Board Member Bruno C Medeiros Celgene Celator Novartis Jazz Pharmaceuticals Astellas Amgen Grant/Research Support/Advisor or Reviewer/Consultant/Honorarium Recipient Grant/Research Support/Advisor or Reviewer/Consultant/Honorarium Recipient Grant/Research Support/Advisor or Reviewer/Consultant/Honorarium Recipient Advisor or Reviewer/Consultant/Honorarium Recipien Grant/Research Support/Consultant/Honorarium Rec Advisor or Reviewer/Consultant/Honorarium Recipien

Joel W Neal clovis CARET?Phys.Resource Mgmt Nektar BI ARMO Biosciences ARIAD Genentech/RocheMERCK Arqule Novartis Exelixis Advisor or Reviewer/Consultant Advisor or Reviewer/Consultant Grant/Research Support/Advisor or Reviewer/Consult Grant/Research Support/Advisor or Reviewer/Consult Advisor or Reviewer/Consultant Advisor or Reviewer/Consultant Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Kavitha J Ramchandran Clovis Oncology Advisor or Reviewer Jonathan W Riess Abbvie MedTronic Ariad Celgene Consultant Consultant Consultant Consultant Mack Roach, III Ferring Accuray Janssen Consultant Consultant Consultant Hope S. Rugo Genentech/Roche Novartis Eisai OBI Plexxikon Merck Macrogenics Pfizer Lilly Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Sandy Srinivas Exelexis Genenetech BMS Astra Zeneca Advisor or Reviewer Advisor or Reviewer/ Honorarium Recipient Advisor or Reviewer Advisor or Reviewer Melinda L Telli Astra Zeneca Vertex Tesaro Genentech PharmaMar Medivation Novatis Abbvie Consultant Grant/Research Support/ Advisor or Reviewer Grant/Research Support/Advisor or Reviewer Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Grant/Research Support Diane Tseng Forty Seven Inc Holder of Intellectual Property Rights

Joseph M Tuscano Celgene Amgen Tackea Grant/Research Support Grant/Research Support Grant/Research Support Alan P Venook Genentech / Roche Merck Serono Bayer Grant/Research Support/ Advisor or Reviewer/Honor Recipient Grant/Research Support/Advisor or Reviewer/Honora Recipient Advisor or Reviewer/HonorariumRecipient Sue S Yom Genentech AstraZeneca UpToDate Varian Medical Systems ‐ foodAbb Laboratories ‐ food Grant/Research Support Honorarium Recipient Holder of Intellectual Property Rights Holder of Intellectual Property Rights This UCSF CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved

• r unlabeled uses of therapeutic products or agents are discussed or referenced.

This activity has been reviewed and approved by members of the UCSF CME Governing Board in accordance with UCSF CME accreditation policies. Office of CME staff, planners, reviewers, and all others in control of content have disclosed no relevant financial relationships.

COURSE COURSE PROGRAM PROGRAM

Fri Friday, ay, Ma March 17, 17, 2017 2017

7:30am Registration and Continental Breakfast 8:30 We Welcome and and Openi Opening Remarks Remarks 8:45 Breast Breast Cance Cancer Tumor Tumor Bo Boar ard Case Cases Helen Helen K.

• K. Che

Chew, MD MD – CHAIR CHAIR Professor of Medicine, The Joe Sullivan Hematology and Oncology Program Director, UC Davis Richard J. Bold, MD, UC Davis Cheryl Ewing, MD, UC San Francisco Kate Horst, MD, Stanford Leslie Oesterich, MD, UC Davis Hope S. Rugo, MD, UC San Francisco George W. Sledge, Jr., MD, Stanford Melinda Telli, MD, Stanford Amanda Wheeler, MD, Stanford 10:45 Break 11:00 Head Head & Ne Neck ck Canc Cancers Tu Tumor mor Boa Board Cases Cases Sue Sue Yom, Yom, MD, MD, PhD PhD – CHAIR CHAIR Associate Professor, Department of Radiation Oncology, UC San Francisco Alain Algazi, MD, UC San Francisco Beth M. Beadle, MD, PhD, Stanford Christopher Chapman, MD, UC San Francisco

• A. Dimitrios Colevas, MD, Stanford

Patrick Ha, MD, UC San Francisco Chris Holsinger, MD, Stanford Jed Katzel, MD, The Permanente Medical Group Shyam Rao, MD, PhD, UC Davis Jonathan Riess, MD, MS, UC Davis 12:00pm Lunch 1:00 He Hematologic matologic Malign lignancies ies Tumor Tumor Bo Boar ard Cases Cases Jason Jason Gotlib tlib, MD MD, MS MS – CHAIR CHAIR Professor of Medicine, Stanford Lloyd Damon, MD, UC San Francisco Brian A. Jonas, MD, PhD, UC Davis Greg Kaufman, MD, Stanford Michaela Liedtke, MD, Stanford Bruno Medeiros, MD, Stanford Aaron Rosenberg, MD, UC Davis Neil Shah, MD, PhD, UC San Francisco Ann Von Gehr, MD, The Permanente Medical Group 3:00 Break 3:15 Thor Thoracic Can Cancer Tum Tumor Bo Boar ard Cases Cases Joel Joel Neal, Neal, MD MD – CHAIR CHAIR Assistant Professor of Medicine (Oncology), Stanford Deepti Behl, MD, Sutter Sacramento Colin Blakely, MD, PhD, UC San Francisco Lisa Brown, MD, UC Davis Megan Daly, MD, UC Davis David Gandara, MD, UC Davis Matthew A. Gubens, MD, MS, UC San Francisco Billy W. Loo, Jr. MD, Stanford Michael Mancuso, MD, Stanford Joseph B. Shrager, MD, Stanford 5:15pm Adjourn 6:00pm We Welcome Rec Recept ption

Satuday, Satuday, Ma March 18, 18, 2017 2017

7:00am Registration and Continental Breakfast 7:45 We Welcome and and Openi Opening Remarks Remarks 8:00 Lymphoma mphoma Tu Tumor mor Bo Boar ard Cas Cases Joseph Joseph Tuscan Tuscano,

• , MD

MD – CH CHAI AIR Professor of Medicine, UC Davis Charalambos (Babis) Andreadis, MD, UC San Francisco Richard Hoppe, MD, Stanford Lawrence Kaplan, MD, UC San Francisco Rajeev Krishnan, MD, UC Davis Ronald Levy, MD, Stanford Lauren Maeda, MD, Stanford 9:30 Break 9:45 End End of

• f Lif

Life Ca Care re Tum Tumor Boa Board Cases Cases Kavitha Kavitha Ram Ramchandr ndran, n, MD– MD– CH CHAI AIR Clinical Assistant Professor; Medical Director, Palliative Medicine and PathWell, Stanford John Hausdorff, MD, Pacific Cancer Care David Magnus, PhD, Stanford Daniel Mirda, MD, Annadel Medical Group Mike Rabow, MD, UC San Francisco Piyush Srivastava, MD, The Permanente Medical Group Diane Tseng, MD, Stanford 11:15 Lunch 12:15pm Geni Genitourinar ary Cance Cancers Tum Tumor Boa Board Cases Cases Charles Charles Ryan, Ryan, MD MD – CHAIR CHAIR Professor of Clinical Medicine and Urology; Thomas Perkins Distinguished Professor in Cancer Research, UC San Francisco Archana Anantharaman, MD, UC San Francisco Mark Buyyounouski, MD, MS, Stanford Andrea Harzsark, MD, The Permanente Medical Group Chong‐Xian Pan, MD, PhD, UC Davis Mack Roach III, MD, UC San Francisco Eila Skinner, MD, Stanford Sandy Srinivas, MD, Stanford 1:45 Break 2:00 Gynocologi Gynocologic Ca Cancers ncers Tu Tumor mor Bo Boar ard Cases Cases Oliver liver Dor Dorigo go, MD MD, PhD PhD – CH CHAI AIR Director and Associate Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford Lee May Chen, MD, UC San Francisco Amer Karam, MD, Stanford Gary Leiserowitz, MD, MS, UC Davis Jyoti Mayadev, MD, UC Davis Jennifer Leah McNally MD, Stanford Bethan Powell, MD, The Permanente Medical Group Betty Suh‐Burgmann, MD, The Permanente Medical Group Stefanie Ueada, MD, UC San Francisco 3:30pm Adjourn

Sunday, Sunday, Ma March 19, 19, 2017 2017

7:00am Registration and Continental Breakfast 7:45 We Welcome and and Openi Opening Remarks Remarks 8:00 Gastrointestina Gastrointestinal Cance Cancers Tum Tumor Bo Boar ard Cases Cases Al Alan an Venook, Venook, MD MD – CHAIR CHAIR The Madden Family Distinguished Professor of Medical Oncology and Translational Research, UC San Francisco Emily Bergsland, MD, UC San Francisco Carlos Corvera, MD, UC San Francisco Mary Feng, MD, UC San Francisco George A. Fisher, MD, PhD, Stanford Edward Kim, MD, PhD, UC Davis Zach Koontz, MD, Pacific Cancer Care Pamela Kunz, MD, Stanford Yan Li, MD, The Permanente Medical Group Margaret Tempero, MD, UC San Francisco Brendan C. Visser, MD, Stanford Carling Ursem, MD, UC San Francisco 9:30 Break 9:45 Sar Sarcoma

• ma Tu

Tumor Bo Boar ard Cases Cases Robert Robert Canter, Canter, MD MD – CHAIR CHAIR Associate Professor of Surgery, Division of Surgical Oncology, UC Davis Lynn Million, MD, Stanford Thierry Jahan, MD, UC San Francisco Ross Okimoto, MD, UC San Francisco Minggui Pan, MD, The Permanente Medical Group Rosanna Wustrack, MD, UC San Francisco 11:15 Break 11:30 Developm Developmental ental Ther Therapeutics apeutics Pamel Pamela Munster Munster, MD MD – CH CHAI AIR Professor of Medicine; Director, Early Phase Clinical Trials; Co‐Director, Center for BRCA Research, UC San Francisco Rahul Aggarwal, MD, UC San Francisco Mallika Dhawan, MD, UC San Francisco Karen Kelly, MD, UC Davis Shivaani Kummar, MD, Stanford Tianhong (Tina) Li, MD, PhD, UC Davis 1:00pm Adjourn

MMJ17026: MMC2017

3/10/2017 University of California San Francisco City, State Name

Registrant List

UCSF OCME Page 1 of 8 1 N/a, N/A Abenojar Jennifer Regacho 2 MD San Mateo, CA Adler Kent 3 MD San Francisco, CA Aggarwal Rahul Raj 4 MD Scotts Valley, CA Alexander Michael 5 MD San Francisco, CA Algazi Alain 6 MD San Francisco, CA Anantharaman Archana 7 MD San Francisco, CA Andreadis Charalambos I. 8 San Jose, CA Antonio Chelsie-Marie Go 9 Petaluma, CA Arino-Lacock Kimberly 10 Md Salinas, CA Aziz Shehzad 11 Bothell, WA Baker Linda 12 San Carlos, CA Ballback Dean 13 MD Modesto, CA Banisadre Mussa 14 PhD Berkeley, CA Bargiacchi Francesca 15 MD Stanford, CA Beadle Beth 16 MD Elk Grove, CA Behl Deepti 17 MBA Fresno, CA Bennett Greg 18 MD San Francisco, CA Bergsland Emily K. 19 MD, PhD San Francisco, CA Blakely Collin 20 Newbury Park, CA Blevins Leslie 21 MD Sacramento, CA Bold Richard 22 RN, MSN Sacramento, CA Bossert Yvonne 23 PharmD Lawrenceville, NJ Boulos Daniel 24 MSN Portland, OR Brady Karen L 25 San Jose, CA Breen Lisa 26 MSN, FNP Folsom, CA Brennan Laura 27 Oakland, CA Brooks Mason 28 MD San Leandro, CA Brophy Nathalie A. 29 MT (ASCP) Fresno, CA Brower John 30 MD San Mateo, CA Brown Jennifer Ann 31 MD Sacramento, CA Brown Lisa 32 MSN, MBA San Ramon, CA Burke Matthew 33 Rocklin, CA Buttweiler Peter 34 MD Stanford, CA Buyyounouski Mark 35 El Dorado Hills, CA Cannata Corey 36 MD Sacramento, CA Canter Robert 37 Avila Beach, CA Caradonna Julie 38 San Ramon, CA Carew Catherine

City, State Name

Registrant List

UCSF OCME Page 2 of 8 39 San Francisco, CA Carmichael Eric 40 PhD, MPH Wilmington, DE Casbas-Hernande Patricia 41 MD Walnut Creek, CA Catalya Esther 42 PharmD Brisbane, CA Chan Cynthia 43 MD San Francisco, CA Chapman Christopher 44 MD Pleasant Hill, CA Chen Gigi 45 MD San Francisco, CA Chen Lee-May 46 MD San Francisco, CA Cheng Judy 47 MD Sacramento, CA Chew Helen 48 MD Vinccennes, IN Chung Tae S. 49 Tacoma, WA Claar Megan 50 PharmD Simi Valley, CA Claghorn David 51 MD Turlock, CA Clement Jincy 52 MD Reno, NV Cohen James Robert 53 MD Stanford, CA Colevas

• A. Dimitrios

54 MD Santa Rosa, CA Comstock Gary 55 MD Reno, NV Conrath

• F. Craig

56 Sanger, CA Cornacchia Lori 57 MD San Francisco, CA Corvera Carlos 58 MPH Pleasanton, CA Costello Hiran 59 MD Sacramento, CA Daly Megan 60 MD San Francisco, CA Damon Lloyd E. 61 Carmel, CA Daste Molly 62 MD Modesto, CA Dhaliwal Amarjit S 63 MD San Francisco, CA Dhawan Mallika Sachdev 64 Turlock, CA Digiovanni Michelle Artadi 65 BS San Rafael, CA Doan Si 66 MD Stanford, CA Dorigo Oliver 67 Paradise Valley, AZ Dragovich Coni 68 MD Napa, CA Dugan Paul 69 San Jose, CA Dunn Whitney 70 Granite Bay, CA Echeverria Deborah 71 PharmD, PhD Draper, UT Edwards James A. 72 MD, PhD San Mateo, CA Ekstrand Brad 73 MD Turlock, CA Eldaly Mohamed 74 RN, BSN San Francisco, CA Evans Molly 75 MD San Francisco, CA Ewing Cheryl 76 MD Novato, CA Fehrenbacher Louis 77 MD San Francisco, CA Feng Mary 78 MD, PhD Stanford, CA Fisher George 79 San Mateo, CA Ford John 80 San Francisco, CA Fowler Brie

City, State Name

Registrant List

UCSF OCME Page 3 of 8 81 PhD San Francisco, CA Fu Christine 82 MD Sacramento, CA Gandara David 83 MD Templeton, CA Ganpule Sanjay 84 RN, OCN Redwood City, CA Garoutte Sherri D. 85 PhD Walnut Creek, CA Garrison Sean 86 MS Piedmont, CA Glasser Ann 87 MD, PhD Menlo Park, CA Goldsmith Mark A. 88 San Jose, CA Gologhlan Renel 89 Visalia, CA Gomes Kim J 90 MD Stanford, CA Gotlib Jason 91 Hayward, CA Graham Karen 92 Long Beach, CA Green Elijah 93 MD Stockton, CA Greenleaf Edward 94 Issaquah, WA Greenwald Gary 95 Palo Alto, CA Greig Christopher 96 PharmD Burlingame, CA Greysen Cindy 97 MD Palo Alto, CA Gruber Joshua 98 MD, MS San Francisco, CA Gubens Matthew Alfred 99 MD San Francisco, CA Ha Patrick 100 Sacramento, CA Hagopian Maral 101 MD Redwood Valley, CA Hardy Russ 102 MD Redwood City, CA Harzstark Andrea 103 MD Monterey, CA Hausdorff John A 104 MD Truckee, CA Heifetz Laurence J. 105 San Carlos, CA Heine April 106 Castro Valley, CA Hernandez Alicia 107 MD Roseville, CA Hersch Julie L. 108 PhD San Francisco, CA Hilger-Rolfe Jacqueline 109 MD Sacramento, CA Ho Gwendolyn 110 MD Walnut Creek, CA Ho Linda 111 MD Stanford, CA Holsinger Chris 112 MD Stanford, CA Hoppe Richard 113 MD Stanford, CA Horst Kathleen 114 San Francisco, CA Huff Alyson 115 PharmD Saratoga, CA Hung Gregory Tien Tsu 116 MD Davis, CA Hutchison Kendra 117 PhD Seattle, WA Israel Mason A 118 BSN Sunnyvale, CA Jackman Irish 119 MD Santa Cruz, CA Jaffe Julie 120 MD San Francisco, CA Jahan Thierry M. 121 PA-C Sutter Creek, CA Johnson Ann 122 Blackhawk, CA Johnson Anne

City, State Name

Registrant List

UCSF OCME Page 4 of 8 123 Morgan Hill, CA Johnson Deborah Jean 124 MD Sacramento, CA Jonas Brian 125 MD Ukiah, CA Joseph Jay 126 San Bruno, CA Juniphant Angela 127 MD Carmichael, CA Kailath John 128 MD Pleasant Hill, CA Kankipati Shoba 129 MD San Francisco, CA Kaplan Lawrence 130 MD Stanford, CA Karam Amer 131 MD Santa Clara, CA Katzel Jed A 132 MD Stanford, CA Kaufman Greg 133 San Francisco, CA Kearney Alisa 134 MD Sacramento, CA Kelly Karen 135 San Francisco, CA Kemby Karen 136 MD Sacramento, CA Kim Edward 137 San Carlos, CA Kim Marie 138 BA, CLS Oakland, CA Kim Susan 139 San Mateo, CA Kindelberger Daniel Bertram 140 MD Morgan Hill, CA Koontz Zach 141 MD San Francisco, CA Kramer Alan M. 142 MBA Dana Point, CA Krekemeyer Laurie 143 MD Sacramento, CA Krishnan Rajeev 144 MD Stanford, CA Kummar Shivaani 145 MD Stanford, CA Kunz Pamela 146 MD San Jose, CA Kwong Myron 147 Redwood City, CA Landgrebe Rachel 148 CMD Scottsdale, AZ Lara Marco Antonio 149 Turlock, CA Leal Wendy 150 Calabasas, CA Lee Erica K. 151 MD Sacramento, CA Leiserowitz Gary 152 PhD San Francisco, CA Lepley Denise 153 MD Foster City, CA Lessin Susan R. 154 MD Stanford, CA Levy Ronald 155 Foster City, CA Lew Joyce 156 MD, PhD Sacramento, CA Li Tianhong 157 MD Oakland, CA Li Yang 158 MD Stanford, CA Liedtke Michaela 159 MD San Francisco, CA Liu Raymond 160 Tempe, AZ Logan John 161 MD, PhD, DABR Stanford, CA Loo Bill 162 American Canyon, CA Luc Tammy 163 PhD Walnut Creek, CA Luciw

• P. Andrew

164 PharmD Moraga, CA Lyle Janet A.

City, State Name

Registrant List

UCSF OCME Page 5 of 8 165 MD Stanford, CA Maeda Lauren 166 MD, Phd Salinas, CA Maghsoudi Kaveh 167 MD Stanford, CA Magnus David 168 MD Travis AFB, CA Malhi Sareena 169 MD Emeryville, CA Malhotra Akshiv 170 MD Stanford, CA Mancuso Michael 171 MD Bowral, NSW, Australia Mangeshikar Tilottama 172 Sacramento, CA Marengo Michael 173 MD Fleming Island, FL Marsland Thomas A 174 Sonoma, CA Mauel Erin 175 MD Sacramento, CA Mayadev Jyoti 176 MD Chico, CA Mazj Sam 177 RN Palo Alto, CA McCarthy Sharon 178 Napa, CA McCoy Carol 179 Rolling Hills, CA McCoy Horace 180 PA-C Santa Cruz, CA McCurdy Alice 181 MN Seattle, WA McGinnis Jeannie 182 PhD San Francisco, CA McGriff Deva 183 MD Santa Cruz, CA McMullen Amy 184 MD, MHS Stanford, CA McNally Jennifer Leah 185 MD Stanford, CA Medeiros Bruno 186 MD Berkeley, CA Melnyk Ostap 187 BS Rancho Murieta, CA Merino Beth 188 MD Stanford, CA Million Lynn 189 MD Koror, PW, Palau Miranda Sheryl 190 MD Napa, CA Mirda Daniel 191 MD Redondo Beach, CA Mirfakhraei Haydeh M 192 Bs San Francisco, CA Miu Jean 193 BS El Dorado Hills, CA Moemeni Sheri 194 PhD Oakland, CA Morris Valerie 195 NP Paradise, CA Mowers Elke 196 East Palo Alto, CA Mundkur Yatin 197 MD San Francisco, CA Munster Pamela N. 198 PharmD Redondo Beach, CA Nakamura Loren 199 MD Fort Lauderdale, FL Nampiaparampil Geetha 200 MD Stanford, CA Neal Joel 201 Danville, CA Neumer Jennifer 202 PharmD San Francisco, CA Nguyen Caroline 203 West Sacramento, CA Nguyen Mai 204 MD Sacramento, CA Oesterich Leslie 205 MD San Francisco, CA Okimoto Ross Alan 206 RN, MSN San Francisco, CA Otani Joanne

City, State Name

Registrant List

UCSF OCME Page 6 of 8 207 Milpitas, CA Pagtama Judy 208 MD Truckee, CA Palmer Daphne 209 MD, PhD Sacramento, CA Pan Chong-Xian 210 MD Santa Clara, CA Pan Minggui 211 Daly City, CA Pangilinan Andrea 212 Temecula, CA Parke Cliff 213 FNP Mountain View, CA Petree Jan 214 PharmD San Jose, CA Pham Rick D. 215 MD San Francisco, CA Powell Bethan 216 MD, PhD Antioch, CA Prasad Gautam 217 BSN Gilbert, AZ Prinkey Natalie 218 MD Manteca, CA Purewal Prabhjit 219 Milpitas, CA Que Charmaine 220 MD San Francisco, CA Rabow Michael 221 MD South San Francisco, CA Rajpal Supriya 222 Los Alamitos, CA Ram Ashwin 223 MD Stanford, CA Ramchandran Kavitha 224 South San Francisco, CA Ramirez Robert 225 MD Sugarland, TX Ramshesh Priya 226 MD Sacramento, CA Rao Shyam 227 MD Sacramento, CA Redmond Gregory 228 MD Davis Reichert Sonia 229 MD, MBA Arcata, CA Richa Elie M 230 Msn Ben Lomond, CA Ricigliano Denise 231 MD Sacramento, CA Riess Jonathan W. 232 MD San Francisco, CA Roach, III Mack 233 Sunnyvale, CA Roldan Elizabeth 234 MD Sacramento, CA Rosenberg Aaron 235 MD Wiliamstown, MA Rosenthal Paul 236 NP Castro Valley, CA Rothman Alana L 237 PharmD Oxnard, CA Rothstein Shellie 238 MD Carmel, CA Rubin Jerry 239 MD San Francisco, CA Rugo Hope S. 240 MD San Francisco, CA Ryan Charles 241 PharmD Yakima, WA Rydholm Nancy 242 RN Redwood City, CA Salom Mary 243 MPA Napa, CA Sanchez Dayna Jyll 244 MD Koror, PW, Palau Santos Glenda Mahia 245 BSN Mountain View, CA Santos Mariel Eliazo 246 MD Roseville, CA Sardar Philip D. 247 MD San Francisco, CA Shah Neil Pravin 248 MD, PhD Jackson, CA Shi Gary

City, State Name

Registrant List

UCSF OCME Page 7 of 8 249 PhD Palo Alto, CA Shieh Felice 250 MD Reno, NV Shields John Albert 251 MD Stanford, CA Shrager Joseph 252 MD Stockton, CA Singh Gaurav 253 MD Walnut Creek, CA Singh Nikki 254 MD Stanford, CA Skinner Eila C. 255 MD Ventura, CA Slater Evan D. 256 MD Stanford, CA Sledge George 257 PharmD Monrovia, CA Smith Maya 258 Msn, Aprn, Aocns Seattle, WA Sorensen Elizabeth 259 MD Stanford, CA Srinivas Sandy 260 MD Walnut Creek, CA Srivastava Piyush 261 Discovery Bay, CA Stanga Andria L. 262 Md Petaluma, CA Stanton Thomas S. 263 PharmD Sacramento, CA Stogsdill Douglas 264 MD Oakland, CA Suh-Burgmann Betty 265 MD Orinda, CA Svahn Tiffany 266 Mill Valley, CA Taskila Tanya 267 MD Santa Rosa, CA Tate David John 268 San Jose, CA Tchoi Allen 269 MD Stanford, CA Telli Melinda 270 MD San Francisco, CA Tempero Margaret 271 BA Rocklin, CA Tomasini Marc 272 MD Antioch, CA Tong Wilson 273 MS Tallahassee, FL Toole Giles 274 Mba Loomis, CA Traynor Sean 275 Stanford, CA Tseng Diane 276 MD Sacramento, CA Tuscano Joseph 277 MD San Francisco, CA Ueada Stefanie 278 MD Napa, CA Umutyan Ari 279 MD San Francisco, CA Ursem Carling Jade 280 MD Santa Rosa, CA Van Roy Ronald L. 281 Emeryville, CA Velasquez Sierra 282 MD San Francisco, CA Venook Alan 283 MD Carmichael, CA Virk Navneet 284 MBS American Canyon, CA Visperas David 285 MD Stanford, CA Visser Brendan 286 MD San Jose, CA Von Gehr Ann 287 Sacramento, CA Wagner Nancy 288 Palo Alto, CA Wall Abby 289 San Jose, CA Walsh Cheryl 290 PharmD San Leandro, CA Wang Tony

City, State Name

Registrant List

UCSF OCME Page 8 of 8 291 MD San Mateo, CA Weller Stephen A 292 RN San Francisco, CA Wertz Victoria Mary 293 MD Stanford, CA Wheeler Amanda 294 MD Davis, CA Williams Melissa Jane 295 MD San Francisco, CA Wolf Jeffrey L. 296 Stockton, CA Wood Margaret 297 MS El Dorado Hills, CA Woody David 298 Danville, CA Wright Brina 299 MD San Francisco, CA Wustrack Rosanna 300 Md Phd Palo Alto, CA Yen Michael 301 MD Lincoln, NE Yiee Kevin 302 MD, PhD San Francisco, CA Yom Sue S. 303 MD Turlock, CA Zaky Sandra 304 PhD San Francisco, CA Zhang Hai Chuck 305 PharmD Woodinville, WA Zhang Ying 306 MD Monterey, CA Zhao Hong 306 Total Number of Attendees for MMJ17026: